Capstone (CAPS) vs PMGC (ELAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Capstone is the larger company by market cap ($1.3 million vs $1.3 million), about 1.0 times the size. Capstone converts more of its revenue into profit, with a net margin of -45.3% versus -1313.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAPS | ELAB |
|---|---|---|
| Share price | $1.44 | $1.14 |
| Market cap | $1.35M | $1.33M |
| 1-day change | -9.15% | -10.24% |
| EPS (TTM) | $-89.68 | $-555.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $46.88M | $590.08K |
| Revenue growth (YoY) | +4.47% | — |
| Net income (latest FY) | $-21.23M | $-7.75M |
| Gross margin | 23.02% | 31.40% |
| Operating margin | -23.43% | — |
| Net margin | -45.28% | -1313.00% |
| 52-week high | $28.50 | $1,344.00 |
| 52-week low | $1.42 | $1.14 |
| Distance from 52-week high | -94.95% | -99.92% |
| Analyst consensus | none | — |
| Avg. price target upside | +108.33% | — |
| Average volume | 153.70K | 279.01K |
| Shares outstanding | 935.38K | 1.17M |
| Employees | 93 | 32 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Capstone is more profitable, keeping -45.3 cents of every revenue dollar as net income versus -1313.0 cents for PMGC.
About Capstone
CAPS stock →Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.
Health Care · Biotechnology: Pharmaceutical Preparations · 93 employees
About PMGC
ELAB stock →PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
CAPS vs ELAB FAQ
Which is bigger, Capstone or PMGC?
Capstone (CAPS) is larger, with a market capitalization of $1.35M compared with $1.33M for PMGC (ELAB).
Are Capstone and PMGC in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.